Liabilities / Assets
58th percentile
Higher debt load relative to assets than 58% of similar nonprofits.
990EZ • Fiscal year 2017 • EIN 45-0494175
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
58th percentile
Higher debt load relative to assets than 58% of similar nonprofits.
Liabilities / Revenue
63rd percentile
Higher debt load relative to revenue than 63% of similar nonprofits.
Net Margin
91st percentile
Higher net margin than 91% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
63rd percentile
Faster asset growth than 63% of similar nonprofits.
Revenue Growth
66th percentile
Faster revenue growth than 66% of similar nonprofits.
Assets
Up$265,488
Up $25,681 (+11%) from 2016
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down$498
Down $114 (-19%) from 2016
Revenue
Up$54,727
Up $6,170 (+13%) from 2016
Expenses
Down$28,932
Down $9,330 (-24%) from 2016
Net Income
Up$25,795
Up $15,500 (+151%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide cancer patients in need with medications and medical expenses associated with their treatment and not otherwise covered by insurance or other agencies. Each patient is eligible to be reimbursed $2.000 per year for medications, protheses, medical supplies and medical expenses. A new patient is eligible for a one-time initial grant of $500 to be used as desired after being diagnosed with cancer or blood disease.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990EZSummary only. Only limited summary data is available for this year.